Effects of MARS on Coagulation in Liver Failure Patients
Author Information
Author(s): Faybik Peter, Bacher Andreas, Kozek-Langenecker Sibylle A, Steltzer Heinz, Krenn Claus Georg, Unger Sandra, Hetz Hubert
Primary Institution: Medical University of Vienna, Austria
Hypothesis
The study aims to evaluate the effects of liver support using a molecular adsorbent recirculating system (MARS) on the coagulation system in patients at high risk of bleeding.
Conclusion
MARS treatment appears to be well tolerated during marked coagulopathy due to liver failure, with stable platelet function despite decreases in platelet count and fibrinogen concentration.
Supporting Evidence
- MARS treatment did not enhance fibrinolysis.
- Platelet function remained stable despite a decrease in platelet count.
- Three moderate bleeding complications were managed without interrupting MARS treatment.
Takeaway
The MARS treatment helps patients with liver problems without making their bleeding issues worse, even though it lowers some blood components.
Methodology
The study involved 61 MARS treatments in 33 patients, with coagulation tests performed before and after treatment.
Potential Biases
The observational nature of the study may introduce biases related to patient selection and treatment administration.
Limitations
The study is retrospective and lacks the structure of a prospective study, and results may not be significant across different patient groups.
Participant Demographics
33 patients (24 men, 9 women) with various liver failure conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website